Diagnostic applications of high-throughput DNA sequencing

Annual Review of Pathology: Mechanisms of Disease

Volumn 8, Issue , 2013, Pages 381-410

  Boyd, Scott D ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cancer; Exome; Genome; Mendelian; Prenatal; Transplant

Indexed keywords

DNA DIRECTED RNA POLYMERASE III; DNA METHYLTRANSFERASE; GENOMIC DNA; RAD51 PROTEIN; RNA POLYMERASE; TRANSCRIPTOME; UNTRANSLATED RNA;

ADAPTIVE IMMUNITY; AMPLICON; CANCER DIAGNOSIS; CANCER GENETICS; CANCER PROGNOSIS; CHROMOSOME 20Q; CHROMOSOME 7Q; CHROMOSOME REARRANGEMENT; CHRONIC OBSTRUCTIVE LUNG DISEASE; CILIARY DYSKINESIA; CITRIC ACID CYCLE; CLINICAL DECISION MAKING; CLONAL EVOLUTION; COMPARATIVE GENOMIC HYBRIDIZATION; CONSENSUS SEQUENCE; COPY NUMBER VARIATION; DISEASE COURSE; DNA SEQUENCE; DNA TEMPLATE; EXPERIMENTAL DESIGN; FALSE POSITIVE RESULT; FOLLOW UP; GASTROINTESTINAL DISEASE; GENE CONTROL; GENE EXPRESSION; GENE FREQUENCY; GENE FUNCTION; GENE MUTATION; GENE REARRANGEMENT; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE PHENOTYPE CORRELATION; GRAFT RECIPIENT; GRAY PLATELET SYNDROME; HAPLOTYPE; HAPLOTYPE MAP; HEMATOLOGIC MALIGNANCY; HEMOPHAGOCYTIC SYNDROME; HERITABILITY; HIGH THROUGHPUT SCREENING; HOMOZYGOSITY; HUMAN; HUMAN GENOME PROJECT; IMMUNOGLOBULIN GENE; INFLUENZA A (H1N1); INFORMED CONSENT; KABUKI MAKEUP SYNDROME; KARYOTYPE; LOSS OF FUNCTION MUTATION; MENTAL RETARDATION MALFORMATION SYNDROME; MINIMAL RESIDUAL DISEASE; MUSCULAR DYSTROPHY; MYELODYSPLASTIC SYNDROME; NONHUMAN; OLIGONUCLEOTIDE PROBE; OPITZ SYNDROME; OSTEOGENESIS IMPERFECTA; OVERALL SURVIVAL; PATIENT CARE; PHASE 3 CLINICAL TRIAL (TOPIC); PHENOTYPE; POLYMERASE CHAIN REACTION; PREDICTIVE VALUE; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; PUBLISHING; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; SOMATIC MUTATION; TRISOMY 21; WORKFLOW; ANIMAL; HIGH THROUGHPUT SEQUENCING; METHODOLOGY; NUCLEOTIDE SEQUENCE;

ANIMALS; BASE SEQUENCE; GENETIC ASSOCIATION STUDIES; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; SEQUENCE ANALYSIS, DNA;

MLCS; MLOWN;

EID: 84875905994     PISSN: 15534006     EISSN: 15534014     Source Type: Book Series    
DOI: 10.1146/annurev-pathol-020712-164026     Document Type: Review

References (156)

1. Mardis ER. 2011. A decade's perspective on DNA sequencing technology. Nature 470:198-2033
2. GilissenC,Hoischen A, BrunnerHG, Veltman JA. 2012. Disease gene identification strategies for exome sequencing. Eur. J. Hum. Genet. 20:490-977
3. Gonzaga-Jauregui C, Lupski JR, Gibbs RA. 2012. Human genome sequencing in health and disease. Annu. Rev. Med. 63:35-611
4. Graubert TA, Mardis ER. 2011. Genomics of acute myeloid leukemia. Cancer J. 17:487-911
5. Mardis ER. 2012. Genome sequencing and cancer. Curr. Opin. Genet. Dev. 22:245-500
6. Lander ES, Linton LM, Birren B, Nusbaum C, Zody MC, et al. 2001. Initial sequencing and analysis of the human genome. Nature 409:860-9211
7. Int. Hum. Genome Seq. Consort. 2004. Finishing the euchromatic sequence of the human genome. Nature 431:931-455
8. MarguliesM, EgholmM, AltmanWE, Attiya S, Bader JS, et al. 2005. Genome sequencing in microfabricated high-density picolitre reactors. Nature 437:376-800
9. Bennett S. 2004. Solexa Ltd. Pharmacogenomics 5:433-388
10. Shendure J, Porreca GJ, Reppas NB, Lin X, McCutcheon JP, et al. 2005. Accurate multiplex polony sequencing of an evolved bacterial genome. Science 309:1728-322
11. Bentley DR, Balasubramanian S, Swerdlow HP, Smith GP,Milton J, et al. 2008. Accurate whole human genome sequencing using reversible terminator chemistry. Nature 456:53-599
12. Boyd SD, Marshall EL, Merker JD, Maniar JM, Zhang LN, et al. 2009. Measurement and clinical monitoring of human lymphocyte clonality by massively parallel VDJ pyrosequencing. Sci. Transl. Med. 1:12ra233
13. Wommack KE, Bhavsar J, Ravel J. 2008. Metagenomics: read length matters. Appl. Environ. Microbiol. 74:1453-633
14. Rothberg JM, Hinz W, Rearick TM, Schultz J, Mileski W, et al. 2011. An integrated semiconductor device enabling non-optical genome sequencing. Nature 475:348-522
15. Eid J, Fehr A, Gray J, Luong K, Lyle J, et al. 2009. Real-time DNA sequencing from single polymerase molecules. Science 323:133-388
16. Harris TD, Buzby PR, Babcock H, Beer E, Bowers J, et al. 2008. Single-molecule DNA sequencing of a viral genome. Science 320:106-99
17. Drmanac R, Sparks AB, Callow MJ, Halpern AL, Burns NL, et al. 2010. Human genome sequencing using unchained base reads on self-assembling DNA nanoarrays. Science 327:78-811
18. Valouev A, Ichikawa J,Tonthat T, Stuart J, Ranade S, et al. 2008. A high-resolution, nucleosome position map of C. elegans reveals a lack of universal sequence-dictated positioning. Genome Res. 18:1051-633
19. Heinrich V, Stange J, Dickhaus T, Imkeller P, Kruger U, et al. 2011. The allele distribution in nextgeneration sequencing data sets is accurately described as the result of a stochastic branching process. Nucleic Acids Res. 40:2426-311
20. Schweiger MR, Kerick M, Timmermann B, Albrecht MW, Borodina T, et al. 2009. Genome-wide massively parallel sequencing of formaldehyde-fixed paraffin-embedded (FFPE) tumor tissues for copy number and mutation analysis. PLoS ONE 4:e55488
21. Robertson G, Hirst M, Bainbridge M, BilenkyM, Zhao Y, et al. 2007. Genome-wide profiles of STAT1 DNA association using chromatin immunoprecipitation and massively parallel sequencing. Nat. Methods 4:651-577
22. Harris RA, Wang T, Coarfa C, Nagarajan RP, Hong C, et al. 2010. Comparison of sequencingbased methods to profile DNA methylation and identification of monoallelic epigenetic modifications. Nat. Biotechnol. 28:1097-1055
23. Albert TJ, Molla MN, Muzny DM, Nazareth L, Wheeler D, et al. 2007. Direct selection of human genomic loci by microarray hybridization. Nat. Methods 4:903-55
24. Hodges E, Xuan Z, Balija V, Kramer M, Molla MN, et al. 2007. Genome-wide in situ exon capture for selective resequencing. Nat. Genet. 39:1522-277
25. Ng PC, Levy S, Huang J, Stockwell TB, Walenz BP, et al. 2008. Genetic variation in an individual human exome. PLoS Genet. 4:e10001600
26. Akhras MS, Unemo M, Thiyagarajan S, Nyren P, Davis RW, et al. 2007. Connector inversion probe technology: a powerful one-primer multiplex DNA amplification system for numerous scientific applications. PLoS ONE 2:e9155
27. Walter MJ, Shen D, Ding L, Shao J, Koboldt DC, et al. 2012. Clonal architecture of secondary acute myeloid leukemia. N. Engl. J. Med. 366:1090-988
28. De Leeneer K, Hellemans J, De Schrijver J, Baetens M, Poppe B, et al. 2011. Massive parallel amplicon sequencing of the breast cancer genes BRCA1 and BRCA2: opportunities, challenges, and limitations. Hum. Mutat. 32:335-444
29. Kohlmann A, Klein HU, Weissmann S, Bresolin S, Chaplin T, et al. 2011. The Interlaboratory RObustness of Next-generation sequencing (IRON) study: a deep sequencing investigation of TET2, CBL and KRAS mutations by an international consortium involving 10 laboratories. Leukemia 25:1840-488
30. Simen BB, Simons JF, Hullsiek KH, Novak RM, Macarthur RD, et al. 2009. Low-abundance drugresistant viral variants in chronically HIV-infected, antiretroviral treatment-naive patients significantly impact treatment outcomes. J. Infect. Dis. 199:693-7011
31. Robins HS,CampregherPV, Srivastava SK,Wacher A, Turtle CJ, et al. 2009. Comprehensive assessment of T cell receptor β-chain diversity in αβT cells. Blood 114:4099-1077
32. Schena M, Shalon D, Davis RW, Brown PO. 1995. Quantitative monitoring of gene expression patterns with a complementary DNA microarray. Science 270:467-700
33. Marioni JC, Mason CE, Mane SM, Stephens M, Gilad Y. 2008. RNA-seq: an assessment of technical reproducibility and comparison with gene expression arrays. Genome Res. 18:1509-177
34. MorinR,Bainbridge M, FejesA,Hirst M, Krzywinski M, et al. 2008. Profiling the HeLa S3 transcriptome using randomly primed cDNA and massively parallel short-read sequencing. Biotechniques 45:81-944
35. Nagalakshmi U, Wang Z, Waern K, Shou C, Raha D, et al. 2008. The transcriptional landscape of the yeast genome defined by RNA sequencing. Science 320:1344-499
36. Mortazavi A,Williams BA, McCue K, Schaeffer L, Wold B. 2008. Mapping and quantifying mammalian transcriptomes by RNA-Seq. Nat. Methods 5:621-288
37. Beck AH,Weng Z,Witten DM, Zhu S, Foley JW, et al. 2010. 3-end sequencing for expression quantification (3SEQ) from archival tumor samples. PLoS ONE 5:e87688
38. Kohane IS,Hsing M, Kong SW. 2012. Taxonomizing, sizing, and overcoming the incidentalome. Genet. Med. 14:399-4044
39. Kohane IS,Masys DR, Altman RB. 2006. The incidentalome: a threat to genomicmedicine. J. Am. Med. Assoc. 296:212-155
40. Int. HapMap Consort. 2003. The International HapMap Project. Nature 426:789-966
41. Sherry ST,WardMH, Kholodov M, Baker J, Phan L, et al. 2001. dbSNP: the NCBI database of genetic variation. Nucleic Acids Res. 29:308-111
42. Altshuler DM, Gibbs RA, Peltonen L, Dermitzakis E, Schaffner SF, et al. 2010. Integrating common and rare genetic variation in diverse human populations. Nature 467:52-588
43. Reich DE, Lander ES. 2001. On the allelic spectrum of human disease. Trends Genet. 17:502-100
44. 1,000 Genomes Proj. Consort. 2010. A map of human genome variation from population-scale sequencing. Nature 467:1061-733
45. Schuster SC, Miller W, Ratan A, Tomsho LP, Giardine B, et al. 2010. Complete Khoisan and Bantu genomes from southern Africa. Nature 463:943-477
46. McKernan KJ, Peckham HE, Costa GL, McLaughlin SF, Fu Y, et al. 2009. Sequence and structural variation in a human genome uncovered by short-read, massively parallel ligation sequencing using two-base encoding. Genome Res. 19:1527-411
47. Kim JI, Ju YS, Park H, Kim S, Lee S, et al. 2009. A highly annotated whole-genome sequence of a Korean individual. Nature 460:1011-155
48. Ahn SM, Kim TH, Lee S, Kim D, GhangH, et al. 2009. The first Korean genome sequence and analysis: full genome sequencing for a socio-ethnic group. Genome Res. 19:1622-299
49. Wheeler DA, Srinivasan M, Egholm M, Shen Y, Chen L, et al. 2008. The complete genome of an individual by massively parallel DNA sequencing. Nature 452:872-766
50. Wang J, Wang W, Li R, Li Y, Tian G, et al. 2008. The diploid genome sequence of an Asian individual. Nature 456:60-655
51. Levy S, SuttonG,Ng PC, Feuk L, Halpern AL, et al. 2007. The diploid genome sequence of an individual human. PLoS Biol. 5:e2544
52. Kitzman JO, Mackenzie AP, Adey A, Hiatt JB, Patwardhan RP, et al. 2011. Haplotype-resolved genome sequencing of a Gujarati Indian individual. Nat. Biotechnol. 29:59-633
53. Bailey JA, Yavor AM, Massa HF, Trask BJ, Eichler EE. 2001. Segmental duplications: organization and impact within the current human genome project assembly. Genome Res. 11:1005-177
54. Redon R, Ishikawa S, Fitch KR, Feuk L, Perry GH, et al. 2006. Global variation in copy number in the human genome. Nature 444:444-544
55. Kidd JM, Cooper GM, DonahueWF, Hayden HS, Sampas N, et al. 2008. Mapping and sequencing of structural variation from eight human genomes. Nature 453:56-644
56. Hanson EH, Imperatore G, Burke W. 2001. HFE gene and hereditary hemochromatosis: a HuGE review. Human Genome Epidemiology. Am. J. Epidemiol. 154:193-2066
57. Fullerton SM, Wolf WA, Brothers KB, Clayton EW, Crawford DC, et al. 2012. Return of individual research results from genome-wide association studies: experience of the Electronic Medical Records and Genomics (eMERGE) Network. Genet. Med. 14:424-311
58. Feder JN, Gnirke A, Thomas W, Tsuchihashi Z, Ruddy DA, et al. 1996. A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat. Genet. 13:399-4088
59. Fletcher LM, Dixon JL, Purdie DM, Powell LW, Crawford DH. 2002. Excess alcohol greatly increases the prevalence of cirrhosis in hereditary hemochromatosis. Gastroenterology 122:281-899
60. Roberts AG, Whatley SD, Morgan RR, Worwood M, Elder GH. 1997. Increased frequency of the haemochromatosis Cys282Tyr mutation in sporadic porphyria cutanea tarda. Lancet 349:321-233
61. Kwak EL, Bang YJ, Camidge DR, Shaw AT, Solomon B, et al. 2010. Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer. N. Engl. J. Med. 363:1693-7033
62. Zhou C, Wu YL, Chen G, Feng J, Liu XQ, et al. 2011. Erlotinib versus chemotherapy as first-line treatment for patients with advanced EGFR mutation-positive non-small-cell lung cancer (OPTIMAL, CTONG-0802): a multicentre, open-label, randomised, phase 3 study. Lancet Oncol. 12:735-422
63. Mok TS, Wu YL, Thongprasert S, Yang CH, Chu DT, et al. 2009. Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma. N. Engl. J. Med. 361:947-577
64. Maemondo M, Inoue A, Kobayashi K, Sugawara S, Oizumi S, et al. 2010. Gefitinib or chemotherapy for non-small-cell lung cancer with mutated EGFR. N. Engl. J. Med. 362:2380-888
65. Amberger J, Bocchini C, Hamosh A. 2011. A new face and new challenges for OnlineMendelian Inheritance in Man (OMIMr ). Hum. Mutat. 32:564-677
66. NgSB,TurnerEH, Robertson PD, Flygare SD, BighamAW,et al. 2009. Targeted capture andmassively parallel sequencing of 12 human exomes. Nature 461:272-766
67. Toydemir RM, Rutherford A, Whitby FG, Jorde LB, Carey JC, Bamshad MJ. 2006. Mutations in embryonicmyosin heavy chain (MYH3) cause Freeman-Sheldon syndrome and Sheldon-Hall syndrome. Nat. Genet. 38:561-655
68. Ng SB, Buckingham KJ, Lee C, Bigham AW, Tabor HK, et al. 2010. Exome sequencing identifies the cause of a mendelian disorder. Nat. Genet. 42:30-355
69. Ng SB, Bigham AW, Buckingham KJ, Hannibal MC, McMillin MJ, et al. 2010. Exome sequencing identifies MLL2 mutations as a cause of Kabuki syndrome. Nat. Genet. 42:790-933
70. Krawitz PM, Schweiger MR, Rodelsperger C, Marcelis C, Kolsch U, et al. 2010. Identity-by-descent filtering of exome sequence data identifies PIGV mutations in hyperphosphatasia mental retardation syndrome. Nat. Genet. 42:827-299
71. Becker J, Semler O, Gilissen C, Li Y, Bolz HJ, et al. 2011. Exome sequencing identifies truncating mutations in human SERPINF1 in autosomal-recessive osteogenesis imperfecta. Am. J. Hum. Genet. 88:362-711
72. Byun M, Abhyankar A, Lelarge V, Plancoulaine S, Palanduz A, et al. 2010. Whole-exome sequencing- based discovery of STIM1 deficiency in a child with fatal classicKaposi sarcoma. J. Exp. Med. 207:2307-122
73. Gilissen C, Arts HH, Hoischen A, Spruijt L,Mans DA, et al. 2010. Exome sequencing identifies WDR35 variants involved in Sensenbrenner syndrome. Am. J. Hum. Genet. 87:418-233
74. Pierce SB, Walsh T, Chisholm KM, Lee MK, Thornton AM, et al. 2010. Mutations in the DBPdeficiency protein HSD17B4 cause ovarian dysgenesis, hearing loss, and ataxia of Perrault syndrome. Am. J. Hum. Genet. 87:282-888
75. Hoischen A, van Bon BW, Gilissen C, Arts P, van Lier B, et al. 2010. De novo mutations of SETBP1 cause Schinzel-Giedion syndrome. Nat. Genet. 42:483-855
76. Hoischen A, van Bon BW, Rodriguez-Santiago B, Gilissen C, Vissers LE, et al. 2011. De novo nonsense mutations in ASXL1 cause Bohring-Opitz syndrome. Nat. Genet. 43:729-311
77. Albers CA, Cvejic A, Favier R, Bouwmans EE, Alessi MC, et al. 2011. Exome sequencing identifies NBEAL2 as the causative gene for gray platelet syndrome. Nat. Genet. 43:735-377
78. Saitsu H, Osaka H, Sasaki M, Takanashi J,HamadaK, et al. 2011. Mutations in POLR3A and POLR3B encoding RNA polymerase III subunits cause an autosomal-recessive hypomyelinating leukoencephalopathy. Am. J. Hum. Genet. 89:644-511
79. Haack TB, Danhauser K, Haberberger B, Hoser J, Strecker V, et al. 2010. Exome sequencing identifies ACAD9 mutations as a cause of complex I deficiency. Nat. Genet. 42:1131-344
80. Musunuru K, Pirruccello JP, Do R, Peloso GM, Guiducci C, et al. 2010. Exome sequencing, ANGPTL3 mutations, and familial combined hypolipidemia. N. Engl. J. Med. 363:2220-277
81. Fujimoto K, Koishi R, Shimizugawa T, Ando Y. 2006. Angptl3-null mice show low plasma lipid concentrations by enhanced lipoprotein lipase activity. Exp. Anim. 55:27-344
82. Depienne C, Bouteiller D, Meneret A, Billot S, Groppa S, et al. 2012. RAD51 haploinsufficiency causes congenital mirror movements in humans. Am. J. Hum. Genet. 90:301-77
83. Lines MA, Huang L, Schwartzentruber J, Douglas SL, Lynch DC, et al. 2012. Haploinsufficiency of a spliceosomal GTPase encoded by EFTUD2 causes mandibulofacial dysostosis with microcephaly. Am. J. Hum. Genet. 90:369-777
84. Zhou C, Zang D, Jin Y,WuH, Liu Z, et al. 2011. Mutation in ribosomal protein L21 underlies hereditary hypotrichosis simplex. Hum. Mutat. 32:710-144
85. Lupski JR, Reid JG, Gonzaga-Jauregui C, Rio Deiros D, Chen DC, et al. 2010. Whole-genome sequencing in a patient with Charcot-Marie-Tooth neuropathy. N. Engl. J. Med. 362:1181-911
86. Choi M, Scholl UI, Ji W, Liu T, Tikhonova IR, et al. 2009. Genetic diagnosis by whole exome capture and massively parallel DNA sequencing. Proc. Natl. Acad. Sci. USA 106:19096-1011
87. Worthey EA, Mayer AN, Syverson GD, Helbling D, Bonacci BB, et al. 2011. Making a definitive diagnosis: successful clinical application of whole exome sequencing in a child with intractable inflammatory bowel disease. Genet. Med. 13:255-622
88. Chapman MA, Lawrence MS, Keats JJ, Cibulskis K, Sougnez C, et al. 2011. Initial genome sequencing and analysis of multiple myeloma. Nature 471:467-722
89. Lee W, Jiang Z, Liu J, Haverty PM, Guan Y, et al. 2010. The mutation spectrum revealed by paired genome sequences from a lung cancer patient. Nature 465:473-777
90. Pasqualucci L, Trifonov V, FabbriG,Ma J, Rossi D, et al. 2011. Analysis of the coding genome of diffuse large B cell lymphoma. Nat. Genet. 43:830-377
91. Ley TJ, Mardis ER, Ding L, Fulton B,McLellan MD, et al. 2008. DNA sequencing of a cytogenetically normal acute myeloid leukaemia genome. Nature 456:66-722
92. Mardis ER, Ding L, Dooling DJ, Larson DE,McLellan MD, et al. 2009. Recurring mutations found by sequencing an acute myeloid leukemia genome. N. Engl. J. Med. 361:1058-666
93. Graubert TA, Mardis ER. 2011. Genomics of acute myeloid leukemia. Cancer J. 17:487-911
94. Zhang J,Ding L,Holmfeldt L,WuG, Heatley SL, et al. 2012. The genetic basis of earlyTcell precursor acute lymphoblastic leukaemia. Nature 481:157-633
95. Tiacci E, Trifonov V, Schiavoni G, Holmes A, Kern W, et al. 2011. BRAF mutations in hairy-cell leukemia. N. Engl. J. Med. 364:2305-155
96. Badalian-Very G, Vergilio JA, Degar BA, MacConaill LE, Brandner B, et al. 2010. Recurrent BRAF mutations in Langerhans cell histiocytosis. Blood 116:1919-233
97. Stephens PJ, Greenman CD, Fu B, Yang F, Bignell GR, et al. 2011. Massive genomic rearrangement acquired in a single catastrophic event during cancer development. Cell 144:27-400
98. Magrangeas F, Avet-Loiseau H, Munshi NC, Minvielle S. 2011. Chromothripsis identifies a rare and aggressive entity among newly diagnosed multiple myeloma patients. Blood 118:675-788
99. Kloosterman WP, Guryev V, van Roosmalen M, Duran KJ, de Bruijn E, et al. 2011. Chromothripsis as a mechanism driving complex de novo structural rearrangements in the germline. Hum. Mol. Genet. 20:1916-244
100. Locasale JW, Grassian AR,Melman T, Lyssiotis CA,Mattaini KR, et al. 2011. Phosphoglycerate dehydrogenase diverts glycolytic flux and contributes to oncogenesis. Nat. Genet. 43:869-744
101. Parsons DW, Jones S, Zhang X, Lin JC, Leary RJ, et al. 2008. An integrated genomic analysis of human glioblastoma multiforme. Science 321:1807-122
102. Morin RD, Johnson NA, Severson TM, Mungall AJ, An J, et al. 2010. Somatic mutations altering EZH2 (Tyr641) in follicular and diffuse large B cell lymphomas of germinal-center origin. Nat. Genet. 42:181-855
103. Morin RD, Mendez-Lago M, Mungall AJ, Goya R, Mungall KL, et al. 2011. Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma. Nature 476:298-3033
104. Ernst T, Chase AJ, Score J, Hidalgo-Curtis CE, Bryant C, et al. 2010. Inactivating mutations of the histone methyltransferase gene EZH2 in myeloid disorders. Nat. Genet. 42:722-266
105. Makishima H, Jankowska AM, Tiu RV, Szpurka H, Sugimoto Y, et al. 2010. Novel homo- and hemizygous mutations in EZH2 in myeloid malignancies. Leukemia 24:1799-8044
106. Nikoloski G, Langemeijer SM, Kuiper RP, Knops R, Massop M, et al. 2010. Somatic mutations of the histone methyltransferase gene EZH2 in myelodysplastic syndromes. Nat. Genet. 42:665-677
107. Ding L, Ley TJ, Larson DE, Miller CA, Koboldt DC, et al. 2012. Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencing. Nature 481:506-100
108. Kassem A, Schopflin A, Diaz C, Weyers W, Stickeler E, et al. 2008. Frequent detection of Merkel cell polyomavirus in human Merkel cell carcinomas and identification of a unique deletion in the VP1 gene. Cancer Res. 68:5009-133
109. Feng H, Shuda M, Chang Y, Moore PS. 2008. Clonal integration of a polyomavirus in human Merkel cell carcinoma. Science 319:1096-1000
110. Paschka P, Schlenk RF, Gaidzik VI, Habdank M, Kronke J, et al. 2010. IDH1 and IDH2 mutations are frequent genetic alterations in acute myeloid leukemia and confer adverse prognosis in cytogenetically normal acute myeloid leukemia with NPM1 mutation without FLT3 internal tandem duplication. J. Clin. Oncol. 28:3636-433
111. Marcucci G, Maharry K,WuYZ,RadmacherMD,MrozekK, et al. 2010.IDH1andIDH2gene mutations identify novel molecular subsets within de novo cytogenetically normal acute myeloid leukemia: aCancer and Leukemia Group B study. J. Clin. Oncol. 28:2348-555
112. Ley TJ, Ding L, Walter MJ, McLellan MD, Lamprecht T, et al. 2010. DNMT3A mutations in acute myeloid leukemia. N. Engl. J. Med. 363:2424-333
113. Patel JP, Gonen M, Figueroa ME, Fernandez H, Sun Z, et al. 2012. Prognostic relevance of integrated genetic profiling in acute myeloid leukemia. N. Engl. J. Med. 366:1079-899
114. Thol F, Kade S, Schlarmann C, Loffeld P, Morgan M, et al. 2012. Frequency and prognostic impact of mutations in SRSF2, U2AF1, and ZRSR2 in patients with myelodysplastic syndromes. Blood 119:3578-844
115. Graubert TA, Shen D, Ding L, Okeyo-Owuor T, Lunn CL, et al. 2012. Recurrent mutations in the U2AF1 splicing factor in myelodysplastic syndromes. Nat. Genet. 44:53-577
116. Yoshida K, Sanada M, Shiraishi Y, Nowak D, Nagata Y, et al. 2011. Frequent pathway mutations of splicing machinery in myelodysplasia. Nature 478:64-699
117. Gelsi-Boyer V, Trouplin V, Adelaide J, Bonansea J, Cervera N, et al. 2009. Mutations of polycombassociated gene ASXL1 in myelodysplastic syndromes and chronic myelomonocytic leukaemia. Br. J. Haematol. 145:788-8000
118. Boultwood J, Perry J, Pellagatti A, Fernandez-Mercado M, Fernandez-Santamaria C, et al. 2010. Frequent mutation of the polycomb-associated gene ASXL1 in the myelodysplastic syndromes and in acute myeloid leukemia. Leukemia 24:1062-655
119. Delhommeau F, Dupont S,Della Valle V, James C,Trannoy S, et al. 2009. Mutation in TET2 in myeloid cancers. N. Engl. J. Med. 360:2289-3011
120. Bejar R, StevensonK, Abdel-WahabO,Galili N, Nilsson B, et al. 2011. Clinical effect of point mutations in myelodysplastic syndromes. N. Engl. J. Med. 364:2496-5066
121. Puente XS, Pinyol M, Quesada V, Conde L, Ordonez GR, et al. 2011. Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia. Nature 475:101-55
122. Wang L, LawrenceMS, Wan Y, Stojanov P, Sougnez C, et al. 2011. SF3B1 and other novel cancer genes in chronic lymphocytic leukemia. N. Engl. J. Med. 365:2497-5066
123. Logan AC, Gao H, Wang C, Sahaf B, Jones CD, et al. 2011. High-throughput VDJ sequencing for quantification of minimal residual disease in chronic lymphocytic leukemia and immune reconstitution assessment. Proc. Natl. Acad. Sci. USA 108:21194-999
124. Leary RJ, Kinde I, Diehl F, Schmidt K, Clouser C, et al. 2010. Development of personalized tumor biomarkers using massively parallel sequencing. Sci. Transl. Med. 2:20ra144
125. Ksiazek TG, Erdman D, Goldsmith CS, Zaki SR, Peret T, et al. 2003. A novel coronavirus associated with severe acute respiratory syndrome. N. Engl. J. Med. 348:1953-666
126. Yozwiak NL, Skewes-Cox P, Stenglein MD, Balmaseda A,Harris E,Derisi JL. 2012. Virus identification in unknown tropical febrile illness cases using deep sequencing. PLoS Negl. Trop. Dis. 6:e14855
127. Wootton SC, Kim DS, Kondoh Y, Chen E, Lee JS, et al. 2011. Viral infection in acute exacerbation of idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 183:1698-7022
128. Yozwiak NL, Skewes-Cox P, Gordon A, Saborio S, Kuan G, et al. 2010. Human enterovirus 109: a novel interspecies recombinant enterovirus isolated from a case of acute pediatric respiratory illness in Nicaragua. J. Virol. 84:9047-588
129. Greninger AL, Holtz L, Kang G, Ganem D, Wang D, DeRisi JL. 2010. Serological evidence of human klassevirus infection. Clin. Vaccine Immunol. 17:1584-888
130. Greninger AL, Runckel C, Chiu CY, Haggerty T, Parsonnet J, et al. 2009. The complete genome of klassevirus - a novel picornavirus in pediatric stool. Virol. J. 6:822
131. Cheval J, Sauvage V, Frangeul L, Dacheux L, Guigon G, et al. 2011. Evaluation of high-throughput sequencing for identifying known and unknown viruses in biological samples. J. Clin. Microbiol. 49:3268- 755
132. Nakamura S, Yang CS, Sakon N, Ueda M, Tougan T, et al. 2009. Direct metagenomic detection of viral pathogens in nasal and fecal specimens using an unbiased high-throughput sequencing approach. PLoS ONE 4:e42199
133. Chiu CY, Greninger AL, Chen EC, Haggerty TD, Parsonnet J, et al. 2010. Cultivation and serological characterization of a humanTheiler's-like cardiovirus associated with diarrheal disease. J. Virol. 84:4407- 144
134. Wright AM, Beres SB, Consamus EN, Long SW, Flores AR, et al. 2011. Rapidly progressive, fatal, inhalation anthrax-like infection in a human: case report, pathogen genome sequencing, pathology, and coordinated response. Arch. Pathol. Lab. Med. 135:1447-599
135. Kennedy AD, OttoM,BraughtonKR, WhitneyAR, Chen L, et al. 2008. Epidemic community-associated methicillin-resistant Staphylococcus aureus: recent clonal expansion and diversification. Proc. Natl. Acad. Sci. USA 105:1327-322
136. Chin CS, Sorenson J, Harris JB, Robins WP, Charles RC, et al. 2011. The origin of the Haitian cholera outbreak strain. N. Engl. J. Med. 364:33-422
137. Rasko DA, Webster DR, Sahl JW, Bashir A, Boisen N, et al. 2011. Origins of the E. coli strain causing an outbreak of hemolytic-uremic syndrome in Germany. N. Engl. J. Med. 365:709-177
138. Nelson MI, Tan Y, Ghedin E, Wentworth DE, St George K, et al. 2011. Phylogeography of the spring and fall waves of the H1N1/09 pandemic influenza virus in the United States. J. Virol. 85:828-344
139. Ghedin E, Laplante J, DePasse J, Wentworth DE, Santos RP, et al. 2011. Deep sequencing reveals mixed infection with 2009 pandemic influenza A (H1N1) virus strains and the emergence of oseltamivir resistance. J. Infect. Dis. 203:168-744
140. Lataillade M, Chiarella J, Yang R, Schnittman S, Wirtz V, et al. 2010. Prevalence and clinical significance of HIV drug resistance mutations by ultra-deep sequencing in antiretroviral-naive subjects in the CASTLE study. PLoS ONE 5:e109522
141. Turnbaugh PJ, HamadyM, Yatsunenko T, Cantarel BL, Duncan A, et al. 2009. A core gut microbiome in obese and lean twins. Nature 457:480-44
142. Backhed F, Ley RE, Sonnenburg JL, Peterson DA, Gordon JI. 2005. Host-bacterial mutualism in the human intestine. Science 307:1915-200
143. Wu YC, Kipling D, Leong HS, Martin V, Ademokun AA, Dunn-Walters DK. 2010. High-throughput immunoglobulin repertoire analysis distinguishes between human IgM memory and switched memory B cell populations. Blood 116:1070-788
144. Venturi V, Quigley MF, Greenaway HY, Ng PC, Ende ZS, et al. 2011. A mechanism for TCR sharing between T cell subsets and individuals revealed by pyrosequencing. J. Immunol. 186:4285-944
145. Campbell PJ,Pleasance ED, StephensPJ, DicksE,Rance R, et al. 2008. Subclonal phylogenetic structures in cancer revealed by ultra-deep sequencing. Proc. Natl. Acad. Sci. USA 105:13081-866
146. Liao HX, Chen X, Munshaw S, Zhang R, Marshall DJ, et al. 2011. Initial antibodies binding to HIV-1 gp41 in acutely infected subjects are polyreactive and highly mutated. J. Exp. Med. 208:2237-499
147. Wu X, Zhou T, Zhu J, Zhang B, Georgiev I, et al. 2011. Focused evolution of HIV-1 neutralizing antibodies revealed by structures and deep sequencing. Science 333:1593-6022
148. Snyder TM, Khush KK, Valantine HA, Quake SR. 2011. Universal noninvasive detection of solid organ transplant rejection. Proc. Natl. Acad. Sci. USA 108:6229-344
149. FanHC, Quake SR. 2010. Sensitivity of noninvasive prenatal detection of fetal aneuploidy from maternal plasma using shotgun sequencing is limited only by counting statistics. PLoS ONE 5:e104399
150. Fan HC, Blumenfeld YJ, Chitkara U, Hudgins L, Quake SR. 2010. Analysis of the size distributions of fetal and maternal cell-free DNA by paired-end sequencing. Clin. Chem. 56:1279-866
151. Fan HC, Blumenfeld YJ, Chitkara U, Hudgins L, Quake SR. 2008. Noninvasive diagnosis of fetal aneuploidy by shotgun sequencing DNA from maternal blood. Proc. Natl. Acad. Sci. USA 105:16266-711
152. Lo YM, Tein MS, Lau TK, Haines CJ, Leung TN, et al. 1998. Quantitative analysis of fetal DNA in maternal plasma and serum: implications for noninvasive prenatal diagnosis. Am. J. Hum. Genet. 62:768-755
153. Chiu RW, Akolekar R, Zheng YW, Leung TY, Sun H, et al. 2011. Non-invasive prenatal assessment of trisomy 21 by multiplexed maternal plasma DNA sequencing: large scale validity study. Br. Med. J. 342:c74011
154. Kitzman JO, Snyder MW, Ventura M, Lewis AP, Qiu R, et al. 2012. Noninvasive whole-genome sequencing of a human fetus. Sci. Transl. Med. 4:137ra766
155. Fan HC, Gu W, Wang J, Blumenfeld YJ, El-Sayed YY, Quake SR. 2012. Non-invasive prenatal measurement of the fetal genome. Nature 487:320-244
156. Shen Y, Zhu YM, Fan X, Shi JY, Wang QR, et al. 2011. Gene mutation patterns and their prognostic impact in a cohort of 1,185 patients with acute myeloid leukemia. Blood 118:5593-6033